Skip to main content
PMC home page
Gut logoLink to Gut
. 1986 Dec;27(12):1498–1501. doi: 10.1136/gut.27.12.1498

Relationship of HLA protein display to activation of 2-5A synthetase in HBe antigen or anti-HBe positive chronic HBV infection.

T Ikeda, M Pignatelli, A M Lever, H C Thomas
PMCID: PMC1433958  PMID: 3804026

Abstract

In this study we have examined the density of HLA class I protein display on the hepatocytes of patients with HBe antigen (HBeAg) or anti-HBe (HBeAb) positive chronic hepatitis B virus (HBV) infection and related this to the level of interferon activation of these cells determined by measuring hepatic oligo 2-5A synthetase activity. In HBeAg positive patients the density of HLA class I (HLA-I) protein was not significantly increased above that found in uninfected liver, but levels of 2-5A synthetase were twice normal. In anti-HBe positive patients, HLA-I density was markedly increased in the presence of normal 2-5A synthetase activity. These data are consistent with type I (alpha or beta) interferon activation of the hepatocytes in HBeAg positive patients and type II (gamma) interferon activity in anti-HBe positive subjects.

Full text

PDF
1498

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barnstable C. J., Bodmer W. F., Brown G., Galfre G., Milstein C., Williams A. F., Ziegler A. Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis. Cell. 1978 May;14(1):9–20. doi: 10.1016/0092-8674(78)90296-9. [DOI] [PubMed] [Google Scholar]
  2. Branca A. A., Baglioni C. Evidence that types I and II interferons have different receptors. Nature. 1981 Dec 24;294(5843):768–770. doi: 10.1038/294768a0. [DOI] [PubMed] [Google Scholar]
  3. Broeze R. J., Dougherty J. P., Pichon J., Jayaram B. M., Lengyel P. Studies with pure mouse Ehrlich ascites tumor interferons alpha and beta: patterns of induction of (2'-5') (A)n synthetase and of a double-stranded RNA-dependent protein kinase in mouse cells and human cells. J Interferon Res. 1981 Feb;1(2):191–202. doi: 10.1089/jir.1981.1.191. [DOI] [PubMed] [Google Scholar]
  4. Durandy A., Virelizier J. L., Griscelli C. Enhancement by interferon of membrane HLA antigens in patients with combined immunodeficiency with defective HLA expression. Clin Exp Immunol. 1983 Apr;52(1):173–178. [PMC free article] [PubMed] [Google Scholar]
  5. Grossberg S. E. The interferons and their inducers: molecular and therapeutic considerations. 1. N Engl J Med. 1972 Jul 6;287(1):13–19. doi: 10.1056/NEJM197207062870104. [DOI] [PubMed] [Google Scholar]
  6. Heron I., Hokland M., Berg K. Enhanced expression of beta2-microglobulin and HLA antigens on human lymphoid cells by interferon. Proc Natl Acad Sci U S A. 1978 Dec;75(12):6215–6219. doi: 10.1073/pnas.75.12.6215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Lengyel P. Biochemistry of interferons and their actions. Annu Rev Biochem. 1982;51:251–282. doi: 10.1146/annurev.bi.51.070182.001343. [DOI] [PubMed] [Google Scholar]
  8. Liaw Y. F., Chu C. M., Su I. J., Huang M. J., Lin D. Y., Chang-Chien C. S. Clinical and histological events preceding hepatitis B e antigen seroconversion in chronic type B hepatitis. Gastroenterology. 1983 Feb;84(2):216–219. [PubMed] [Google Scholar]
  9. Mondelli M., Vergani G. M., Alberti A., Vergani D., Portmann B., Eddleston A. L., Williams R. Specificity of T lymphocyte cytotoxicity to autologous hepatocytes in chronic hepatitis B virus infection: evidence that T cells are directed against HBV core antigen expressed on hepatocytes. J Immunol. 1982 Dec;129(6):2773–2778. [PubMed] [Google Scholar]
  10. Montano L., Miescher G. C., Goodall A. H., Wiedmann K. H., Janossy G., Thomas H. C. Hepatitis B virus and HLA antigen display in the liver during chronic hepatitis B virus infection. Hepatology. 1982 Sep-Oct;2(5):557–561. doi: 10.1002/hep.1840020508. [DOI] [PubMed] [Google Scholar]
  11. Pignatelli M., Waters J., Brown D., Lever A., Iwarson S., Schaff Z., Gerety R., Thomas H. C. HLA class I antigens on the hepatocyte membrane during recovery from acute hepatitis B virus infection and during interferon therapy in chronic hepatitis B virus infection. Hepatology. 1986 May-Jun;6(3):349–353. doi: 10.1002/hep.1840060303. [DOI] [PubMed] [Google Scholar]
  12. Schattner A., Wallach D., Merlin G., Hahn T., Levin S., Ramot B., Revel M. Variation of (2'-5') oligo A synthetase level in lymphocytes and granulocytes of patients with viral infections and leukemia. J Interferon Res. 1982;2(3):355–361. doi: 10.1089/jir.1982.2.355. [DOI] [PubMed] [Google Scholar]
  13. Toy J. L. The interferons. Clin Exp Immunol. 1983 Oct;54(1):1–13. [PMC free article] [PubMed] [Google Scholar]
  14. Wallach D., Fellous M., Revel M. Preferential effect of gamma interferon on the synthesis of HLA antigens and their mRNAs in human cells. Nature. 1982 Oct 28;299(5886):833–836. doi: 10.1038/299833a0. [DOI] [PubMed] [Google Scholar]
  15. Weller I. V., Bassendine M. F., Murray A. K., Craxi A., Thomas H. C., Sherlock S. Effects of prednisolone/azathioprine in chronic hepatitis B viral infection. Gut. 1982 Aug;23(8):650–655. doi: 10.1136/gut.23.8.650. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Wheelock E. F. Interferon-Like Virus-Inhibitor Induced in Human Leukocytes by Phytohemagglutinin. Science. 1965 Jul 16;149(3681):310–311. doi: 10.1126/science.149.3681.310. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES